Panov G, Dyulgerova S, Panova P, Stefanova S
Biomedicines. 2024; 12(11).
PMID: 39595210
PMC: 11592192.
DOI: 10.3390/biomedicines12112646.
Zhang J, Toulopoulou T, Li Q, Niu L, Peng L, Dai H
Psychol Med. 2024; :1-12.
PMID: 39564744
PMC: 11650199.
DOI: 10.1017/S0033291724001673.
Fotiadis P, Parkes L, Davis K, Satterthwaite T, Shinohara R, Bassett D
Nat Rev Neurosci. 2024; 25(10):688-704.
PMID: 39103609
DOI: 10.1038/s41583-024-00846-6.
Reznik A, Syunyakov T, Akhmerova I, Butylin D, Vasilenko A, Gvozdetckii A
Consort Psychiatr. 2024; 3(3):56-70.
PMID: 39044917
PMC: 11262118.
DOI: 10.17816/CP172.
Mosolov S
Consort Psychiatr. 2024; 1(2):29-42.
PMID: 39006901
PMC: 11240135.
DOI: 10.17650/2712-7672-2020-1-2-29-42.
The Psychotherapy of Schizophrenia: A Review of the Evidence for Psychodynamic and Nonpsychodynamic Treatments.
Ruffalo M
Psychiatry Clin Psychopharmacol. 2024; 33(3):222-228.
PMID: 38765312
PMC: 11082629.
DOI: 10.5152/pcp.2023.23627.
Treatment of Depression with Vortioxetine and Second Generation Antipsychotics During the Period of Remission Formation in Schizophrenia (Interim Data Analysis).
Reznik A, Syunyakov T, Mudrak A, Zakharov N, Popova Z, Khoroshilova A
Consort Psychiatr. 2024; 4(1):18-36.
PMID: 38239568
PMC: 10790730.
DOI: 10.17816/CP3728.
Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia.
Lang X, Zang X, Yu F, Xiu M
Front Pharmacol. 2023; 14:1166507.
PMID: 37153770
PMC: 10160398.
DOI: 10.3389/fphar.2023.1166507.
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro).
Kjelby E, Gjestad R, Fathian F, Sinkeviciute I, Alisauskiene R, Anda L
J Clin Psychopharmacol. 2023; 43(3):246-258.
PMID: 37083542
PMC: 10155702.
DOI: 10.1097/JCP.0000000000001679.
Preliminary evidence that fatigue contributes to anhedonia in stable individuals diagnosed with schizophrenia.
Laraki Y, Bayard S, Decombe A, Capdevielle D, Raffard S
Front Psychiatry. 2023; 14:1098932.
PMID: 36778632
PMC: 9911435.
DOI: 10.3389/fpsyt.2023.1098932.
Changes in major psychiatric disorders in children and adolescents from 2001 to 2020: A retrospective single-center study.
Zheng H, Jiang X, Yang R, Wang S, Zhong H
Front Psychiatry. 2023; 13:1079456.
PMID: 36699486
PMC: 9868601.
DOI: 10.3389/fpsyt.2022.1079456.
Cerebellar stimulation in schizophrenia: A systematic review of the evidence and an overview of the methods.
Hua J, Abram S, Ford J
Front Psychiatry. 2023; 13:1069488.
PMID: 36620688
PMC: 9815121.
DOI: 10.3389/fpsyt.2022.1069488.
Advanced brain age correlates with greater rumination and less mindfulness in schizophrenia.
Abram S, Roach B, Hua J, Han L, Mathalon D, Ford J
Neuroimage Clin. 2022; 37:103301.
PMID: 36586360
PMC: 9830317.
DOI: 10.1016/j.nicl.2022.103301.
Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents.
Zmudzka E, Lustyk K, Gluch-Lutwin M, Mordyl B, Zakrzewska-Sito A, Mierzejewski P
Int J Mol Sci. 2022; 23(24).
PMID: 36555568
PMC: 9781916.
DOI: 10.3390/ijms232415929.
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature.
Giordano G, Brando F, Pezzella P, De Angelis M, Mucci A, Galderisi S
Front Psychiatry. 2022; 13:970210.
PMID: 36117655
PMC: 9476599.
DOI: 10.3389/fpsyt.2022.970210.
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study.
Correll C, Koblan K, Hopkins S, Li Y, Dworak H, Goldman R
NPJ Schizophr. 2021; 7(1):63.
PMID: 34887427
PMC: 8660889.
DOI: 10.1038/s41537-021-00190-z.
HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation.
Mikulska J, Juszczyk G, Gawronska-Grzywacz M, Herbet M
Brain Sci. 2021; 11(10).
PMID: 34679364
PMC: 8533829.
DOI: 10.3390/brainsci11101298.
Predictors of unrecognised comorbid depression in patients with schizophrenia at Amanuel mental specialized hospital, Ethiopia: a cross-sectional study.
Ayalew M, Reta Y, Defar S
BMJ Open. 2021; 11(9):e049026.
PMID: 34556512
PMC: 8461692.
DOI: 10.1136/bmjopen-2021-049026.
Long-Term Outcomes and Predictors of Childhood-Onset Schizophrenia: A Naturalistic Study of 6-year Follow-Up in China.
Liangrong Z, Guican Z, Qi Z, Weirui Y, Yaqi Z, Tong L
Front Psychiatry. 2021; 12:679807.
PMID: 34393845
PMC: 8360848.
DOI: 10.3389/fpsyt.2021.679807.
Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review.
Maini K, Gould H, Hicks J, Iqbal F, Patterson 2nd J, Edinoff A
Neurol Int. 2021; 13(3):279-296.
PMID: 34287335
PMC: 8293312.
DOI: 10.3390/neurolint13030029.